# Determination of Blood Loss After CS

> **NCT04549012** · EARLY_PHASE1 · UNKNOWN · sponsor: **Ain Shams University** · enrollment: 130 (estimated)

## Conditions studied

- Effect of Drug

## Interventions

- **DRUG:** Tranexamic acid
- **DRUG:** Oxytocin

## Key facts

- **NCT ID:** NCT04549012
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-09
- **Primary completion:** 2021-09
- **Final completion:** 2021-10
- **Target enrollment:** 130 (ESTIMATED)
- **Last updated:** 2020-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04549012

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04549012, "Determination of Blood Loss After CS". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04549012. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*